|
1
|
American Cancer Society: Cancer Facts
& Figures 2015. Atlanta: American Cancer Society; 2015,
https://www.cancer.org/research/cancer-facts-statistics.html.
|
|
2
|
Xie J, Dong H, Chen H, Zhao R, Sinko PJ,
Shen W, Wang J, Lu Y, Yang X, Xie F, et al: Exploring cancer
metastasis prevention strategy: Interrupting adhesion of cancer
cells to vascular endothelia of potential metastatic tissues by
antibody-coated nanomaterial. J Nanobiotechnology. 13:92015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arvelo F, Sojo F and Cotte C: Cancer and
the metastatic substrate. Ecancermedicalscience. 10:7012016.
View Article : Google Scholar
|
|
4
|
Xu J, Qin X, Wang J, Zhang S, Zhong Y, Ren
L, Wei Y, Zeng S, Wan D and Zheng S; Society of Surgery; Chinese
Medical Association; Committee of Colorectal Cancer, Chinese
Anticancer Association: Chinese guidelines for the diagnosis and
comprehensive treatment of hepatic metastasis of colorectal cancer.
J Cancer Res Clin Oncol. 137:1379–1396. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu Y, Wang G, Yang Y, Mei Z, Liang Z, Cui
A, Wu T, Liu CY and Cui L: Increased TEAD4 expression and nuclear
localization in colorectal cancer promote epithelial-mesenchymal
transition and metastasis in a YAP-independent manner. Oncogene.
35:2789–2800. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma H, Gao L, Li S, Qin J, Chen L, Liu X,
Xu P, Wang F, Xiao H, Zhou S, et al: CCR7 enhances TGF-β1-induced
epithelial-mesenchymal transition and is associated with lymph node
metastasis and poor overall survival in gastric cancer. Oncotarget.
6:24348–24360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Atmaca A, Wirtz RW, Werner D, Steinmetz K,
Claas S, Brueckl WM, Jäger E and Al-Batran SE: SNAI2/SLUG and
estrogen receptor mRNA expression are inversely correlated and
prognostic of patient outcome in metastatic non-small cell lung
cancer. BMC Cancer. 15:3002015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yuan H, Kajiyama H, Ito S, Chen D, Shibata
K, Hamaguchi M, Kikkawa F and Senga T: HOXB13 and ALX4 induce SLUG
expression for the promotion of EMT and cell invasion in ovarian
cancer cells. Oncotarget. 6:13359–13370. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Palma-Nicolás JP and López-Colomé AM:
Thrombin induces slug-mediated E-cadherin transcriptional
repression and the parallel upregulation of N-cadherin by a
transcription-independent mechanism in RPE cells. J Cell Physiol.
228:581–589. 2013. View Article : Google Scholar
|
|
10
|
Xie Y, Liu S, Lu W, Yang Q, Williams KD,
Binhazim AA, Carver BS, Matusik RJ and Chen Z: Slug regulates
E-cadherin repression via p19Arf in prostate tumorigenesis. Mol
Oncol. 8:1355–1364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vuoriluoto K, Haugen H, Kiviluoto S,
Mpindi JP, Nevo J, Gjerdrum C, Tiron C, Lorens JB and Ivaska J:
Vimentin regulates EMT induction by Slug and oncogenic H-Ras and
migration by governing Axl expression in breast cancer. Oncogene.
30:1436–1448. 2011. View Article : Google Scholar
|
|
12
|
Xia J, Wu Z, Yu C, He W, Zheng H, He Y,
Jian W, Chen L, Zhang L and Li W: miR-124 inhibits cell
proliferation in gastric cancer through downregulation of SPHK1. J
Pathol. 227:470–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pan J, Tao YF, Zhou Z, Cao BR, Wu SY,
Zhang YL, Hu SY, Zhao WL, Wang J, Lou GL, et al: An novel role of
sphingosine kinase-1 (SPHK1) in the invasion and metastasis of
esophageal carcinoma. J Transl Med. 9:1572011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Z, Yan Z, Yuan Z, Sun Y, He H and
Mai C: SPHK1 inhibitor suppresses cell proliferation and invasion
associated with the inhibition of NF-κB pathway in hepatocellular
carcinoma. Tumour Biol. 36:1503–1509. 2015. View Article : Google Scholar
|
|
15
|
Chen K, Pan Q, Gao Y, Yang X, Wang S,
Peppelenbosch MP and Kong X: DMS triggers apoptosis associated with
the inhibition of SPHK1/NF-κB activation and increase in
intracellular Ca2+ concentration in human cancer cells.
Int J Mol Med. 33:17–24. 2014.
|
|
16
|
Xiong H, Wang J, Guan H, Wu J, Xu R, Wang
M, Rong X, Huang K, Huang J, Liao Q, et al: SphK1 confers
resistance to apoptosis in gastric cancer cells by downregulating
Bim via stimulating Akt/FoxO3a signaling. Oncol Rep. 32:1369–1373.
2014.PubMed/NCBI
|
|
17
|
Liu SQ, Su YJ, Qin MB, Mao YB, Huang JA
and Tang GD: Sphingosine kinase 1 promotes tumor progression and
confers malignancy phenotypes of colon cancer by regulating the
focal adhesion kinase pathway and adhesion molecules. Int J Oncol.
42:617–626. 2013.
|
|
18
|
Ni M, Shi XL, Qu ZG, Jiang H, Chen ZQ and
Hu J: Epithelial mesenchymal transition of non-small-cell lung
cancer cells A549 induced by SPHK1. Asian Pac J Trop Med.
8:142–146. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Golubovskaya VM: Targeting FAK in human
cancer: From finding to first clinical trials. Front Biosci
(Landmark Ed). 19:687–706. 2014. View
Article : Google Scholar
|
|
20
|
Wilson C, Nicholes K, Bustos D, Lin E,
Song Q, Stephan JP, Kirkpatrick DS and Settleman J: Overcoming
EMT-associated resistance to anti-cancer drugs via Src/FAK pathway
inhibition. Oncotarget. 5:7328–7341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kuo TC, Tan CT, Chang YW, Hong CC, Lee WJ,
Chen MW, Jeng YM, Chiou J, Yu P, Chen PS, et al: Angiopoietin-like
protein 1 suppresses SLUG to inhibit cancer cell motility. J Clin
Invest. 123:1082–1095. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gassowska M, Cieslik M, Wilkaniec A and
Strosznajder JB: Sphingosine kinases/sphingosine-1-phosphate and
death Signalling in APP-transfected cells. Neurochem Res.
39:645–652. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Crompton BD, Carlton AL, Thorner AR,
Christie AL, Du J, Calicchio ML, Rivera MN, Fleming MD, Kohl NE,
Kung AL, et al: High-throughput tyrosine kinase activity profiling
identifies FAK as a candidate therapeutic target in Ewing sarcoma.
Cancer Res. 73:2873–2883. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Gao D, Wang H, Li X, Yang J, Yan X,
Liu Z and Ma Z: Negative feedback loop between p66Shc and ZEB1
regulates fibrotic EMT response in lung cancer cells. Cell Death
Dis. 6:e17082015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tiwari N, Gheldof A, Tatari M and
Christofori G: EMT as the ultimate survival mechanism of cancer
cells. Semin Cancer Biol. 22:194–207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z and You
T: HMGA2 induces transcription factor Slug expression to promote
epithelial-to-mesenchymal transition and contributes to colon
cancer progression. Cancer Lett. 355:130–140. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rogers CD, Saxena A and Bronner ME: Sip1
mediates an E-cadherin-to-N-cadherin switch during cranial neural
crest EMT. J Cell Biol. 203:835–847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang X, Liu G, Kang Y, Dong Z, Qian Q and
Ma X: N-cadherin expression is associated with acquisition of EMT
phenotype and with enhanced invasion in erlotinib-resistant lung
cancer cell lines. PLoS One. 8:e576922013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
da Silva SD, Morand GB, Alobaid FA, Hier
MP, Mlynarek AM, Alaoui-Jamali MA and Kowalski LP:
Epithelial-mesenchymal transition (EMT) markers have prognostic
impact in multiple primary oral squamous cell carcinoma. Clin Exp
Metastasis. 32:55–63. 2015. View Article : Google Scholar
|
|
30
|
Taliaferro-Smith L, Oberlick E, Liu T,
McGlothen T, Alcaide T, Tobin R, Donnelly S, Commander R, Kline E,
Nagaraju GP, et al: FAK activation is required for IGF1R-mediated
regulation of EMT, migration, and invasion in mesenchymal triple
negative breast cancer cells. Oncotarget. 6:4757–4772. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
John JK, Paraiso KH, Rebecca VW, Cantini
LP, Abel EV, Pagano N, Meggers E, Mathew R, Krepler C, Izumi V, et
al: GSK3β inhibition blocks melanoma cell/host interactions by
downregulating N-cadherin expression and decreasing FAK
phosphorylation. J Invest Dermatol. 132:2818–2827. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Datta A, Loo SY, Huang B, Wong L, Tan SS,
Tan TZ, Lee SC, Thiery JP, Lim YC, Yong WP, et al: SPHK1 regulates
proliferation and survival responses in triple-negative breast
cancer. Oncotarget. 5:5920–5933. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huo C, Kao YH and Chuu CP: Androgen
receptor inhibits epithelial-mesenchymal transition, migration, and
invasion of PC-3 prostate cancer cells. Cancer Lett. 369:103–111.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng G, Liu C, Sun X, Zhang L, Liu L,
Ouyang J and Li B: Visfatin promotes osteosarcoma cell migration
and invasion via induction of epithelial-mesenchymal transition.
Oncol Rep. 34:987–994. 2015.PubMed/NCBI
|
|
35
|
Räsänen K and Vaheri A: TGF-beta1 causes
epithelial-mesenchymal transition in HaCaT derivatives, but induces
expression of COX-2 and migration only in benign, not in malignant
keratinocytes. J Dermatol Sci. 58:97–104. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen MB, Yang L, Lu PH, Fu XL, Zhang Y,
Zhu YQ and Tian Y: MicroRNA-101 downregulates sphingosine kinase 1
in colorectal cancer cells. Biochem Biophys Res Commun.
463:954–960. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Stewart JE, Ma X, Megison M, Nabers H,
Cance WG, Kurenova EV and Beierle EA: Inhibition of FAK and VEGFR-3
binding decreases tumorigenicity in neuroblastoma. Mol Carcinog.
54:9–23. 2015. View
Article : Google Scholar :
|
|
39
|
Hsieh YS, Chu SC, Hsu LS, Chen KS, Lai MT,
Yeh CH and Chen PN: Rubus idaeus L. reverses
epithelial-to-mesenchymal transition and suppresses cell invasion
and protease activities by targeting ERK1/2 and FAK pathways in
human lung cancer cells. Food Chem Toxicol. 62:908–918. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen KS, Shi MD, Chien CS and Shih YW:
Pinocembrin suppresses TGF-β1-induced epithelial-mesenchymal
transition and metastasis of human Y-79 retinoblastoma cells
through inactivating αvβ3 integrin/FAK/p38α signaling pathway. Cell
Biosci. 4:412014. View Article : Google Scholar
|
